Does HEPATITIS A VIRUS STRAIN 326F ANTIGEN Cause Hypoaesthesia? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Hypoaesthesia have been filed in association with HEPATITIS A VIRUS STRAIN 326F ANTIGEN (VAQTA). This represents 13.0% of all adverse event reports for HEPATITIS A VIRUS STRAIN 326F ANTIGEN.
6
Reports of Hypoaesthesia with HEPATITIS A VIRUS STRAIN 326F ANTIGEN
13.0%
of all HEPATITIS A VIRUS STRAIN 326F ANTIGEN reports
0
Deaths
6
Hospitalizations
How Dangerous Is Hypoaesthesia From HEPATITIS A VIRUS STRAIN 326F ANTIGEN?
Of the 6 reports, 6 (100.0%) required hospitalization.
Is Hypoaesthesia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for HEPATITIS A VIRUS STRAIN 326F ANTIGEN. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does HEPATITIS A VIRUS STRAIN 326F ANTIGEN Cause?
No adverse event (23)
Product storage error (12)
Asthenia (10)
Loss of personal independence in daily activities (8)
Diarrhoea (7)
Paraesthesia (7)
Abdominal discomfort (6)
Acute sinusitis (6)
Cardiovascular disorder (6)
Cognitive disorder (6)
What Other Drugs Cause Hypoaesthesia?
ADALIMUMAB (7,423)
ETANERCEPT (4,497)
METHOTREXATE (4,175)
RITUXIMAB (3,605)
TOFACITINIB (3,324)
PREDNISONE (3,239)
TOCILIZUMAB (3,238)
FINGOLIMOD (3,180)
LENALIDOMIDE (3,127)
SECUKINUMAB (3,079)